Home » Newsletters » BioWorld Science

BioWorld Science

July 15, 2009

View Archived Issues

Enanta Pharmaceuticals claims new NS3/NS4A protease inhibitors for the treatment of HCV

MaxThera presents novel PPAT inhibitors for the treatment of bacterial infections

Novel PDE10A inhibitors in early development at BioTie Therapies as antipsychotics

Purdue Pharma discovers opioid receptor agonists and antagonists for the treatment of constipation

Novavax and Cadila launch joint venture in India

Merck & Co. and Portola sign worldwide license agreement for betrixaban

Spectrum submits response to FDA's complete response letter regarding sBLA for Zevalin

TRION reports new data on the mechanism of action of ertumaxomab

Discreet effect of rosiglitazone on vascular disease progression in prediabetic patients

Novel alpha7 nAChR agonist EVP-5141 improves cognitive ability in vivo

Vertex plans to sell rights to certain milestone payments related to telaprevir in Europe

AstraZeneca and MAP Pharmaceuticals terminate license agreement for unit dose budesonide

Addex achieves second preclinical milestone under PD collaboration with Merck & Co.

Sorafenib evaluated in different subtypes of recurrent or metastatic sarcoma

Sunitinib active in phase II non-GIST stromal tumor sarcomas trial

Cellceutix reports successful animal testing data for Kevetrin in lung cancer cell lines

Evotec enters fragment-based drug discovery agreement with Cubist

MediciNova proposes final protocol for phase II MN-221 trial in asthma

Can-Fite BioPharma receives approval to commence phase I/II trial for CF-102 in hepatitis C

Sunesis receives milestone payment from Biogen Idec for selection of Raf kinase inhibitor

PharmaMar releases statement regarding FDA oral session to discuss Yondelis

Hisamitsu to acquire Noven for USD 428 million in an all-cash tender offer

NovaMed signs agreements with Iroko and EUSA Pharma

PharmaSurgics completes phase I study of PXL-01 for postsurgical adhesion formation

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...